GWM
BIB icon

Geneos Wealth Management’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Geneos Wealth Management’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100
Closed -$6K – 2598
2022
Q1 		$6K Hold
100
– – ﹤0.01% 2261
2021
Q4 		$8K Sell
100
-202,776
-100% -$17.4M ﹤0.01% 2253
2021
Q3 		$18.5M Buy
202,876
+202,776
+202,776% +$20.5M 0.71% 27
2021
Q2 		$9K Hold
100
– – ﹤0.01% 2222
2021
Q1 		$8K Hold
100
– – ﹤0.01% 2456
2020
Q4 		$8K Hold
100
– – ﹤0.01% 2292
2020
Q3 		$6K Sell
100
-120,417
-100% -$8.54M ﹤0.01% 2104
2020
Q2 		$8.54M Buy
120,517
+120,334
+65,756% +$7.68M 0.48% 41
2020
Q1 		$7K Sell
183
-101,270
-100% -$5.64M ﹤0.01% 1925
2019
Q4 		$6.35M Buy
101,453
+101,270
+55,339% +$5.4M 0.34% 72
2019
Q3 		$7K Hold
183
– – ﹤0.01% 1994
2019
Q2 		$9K Hold
183
– – ﹤0.01% 1928
2019
Q1 		$10K Hold
183
– – ﹤0.01% 1830
2018
Q4 		$7K Sell
183
-57,450
-100% -$3M ﹤0.01% 1868
2018
Q3 		$4.01M Buy
57,633
+57,450
+31,393% +$3.76M 0.27% 107
2018
Q2 		$10K Hold
183
– – ﹤0.01% 1709
2018
Q1 		$10K Hold
183
– – ﹤0.01% 1632
2017
Q4 		$10K Sell
183
-32,300
-99% -$1.82M ﹤0.01% 1623
2017
Q3 		$1.99M Buy
32,483
+32,300
+17,650% +$1.84M 0.2% 124
2017
Q2 		$9K Hold
183
– – ﹤0.01% 1561
2017
Q1 		$8K Hold
183
– – ﹤0.01% 1545
2016
Q4 		$7K Hold
183
– – ﹤0.01% 1527
2016
Q3 		$8K Buy
183
+100
+120% +$4.75K ﹤0.01% 1429
2016
Q2 		$3K Hold
83
– – ﹤0.01% 1604
2016
Q1 		$3K Buy
+83
New +$3.67K ﹤0.01% 1589

Other funds holding BIB

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
MCC
Money Concepts Capital Palm Beach Gardens, Florida $1.81B AUM 21.93% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Geneos Wealth Management's BIB Position: Q2 2022 in Review

Geneos Wealth Management sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q2 2022, closing a stake of 100 shares — an estimated $6K sold.

Geneos Wealth Management first reported a position in BIB in Q1 2016 and held it in 25 quarters. The position peaked at $18.5M in Q3 2021. 24 funds tracked by Wall St. Rank hold BIB as of Q2 2022.

  • Geneos Wealth Management reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q2 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 100 ProShares Ultra NASDAQ Biotechnology shares in Q2 2022, an estimated $6K.
  • Geneos Wealth Management first reported a position in ProShares Ultra NASDAQ Biotechnology in Q1 2016 and held it in 25 quarters.
  • Geneos Wealth Management's ProShares Ultra NASDAQ Biotechnology position peaked at $18.5M in Q3 2021.
  • 24 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q2 2022.

Based on Geneos Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.